Understanding immune function and dysfunction.
Monash University has signed a major multiyear research and commercialisation deal with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the early detection and prevention of rheumatoid arthritis, a debilitating autoimmune disease which affects more than 400,000 Australians1 and more than 24.5 million people worldwide2. The agreement was […]
Janssen Biotech funds Monash rheumatoid arthritis research Janssen Biotech, part of global giant Johnson & Johnson, has agreed to fund research by a team of scientists led by one of Monash University’s star researchers into rheumatoid arthritis. The landmark deal means Janssen will have first dibs on new medicines emerging from a research team led […]
Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type 1 diabetes, multiple sclerosis, and Crohn’s disease. Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type […]
Australian scientists have solved a 40-year old mystery and shed light on an evolutionary arms race played out between cytomegalovirus (CMV) and the immune system. Human CMV, also known as human herpesvirus 5, infects more than 50 per cent of adults worldwide and is the leading cause of birth defects in the developed world. Research […]
Monash University’s Biomedicine Discovery Institute (BDI) and Cardiff University’s Systems Immunity Research Institute have signed a memorandum of understanding (MOU) that will see the two institutes extend their collaborative activities. The five year mutual agreement recognises highly productive joint projects already being conducted around inflammation and immunity, and provides a mechanism for enabling additional projects in the […]
